These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15588434)

  • 1. Evaluation of N-terminal pro-B type natriuretic peptide analysis on the Elecsys 1010 and 2010 analysers.
    Barnes SC; Collinson PO; Galasko G; Lahiri A; Senior R
    Ann Clin Biochem; 2004 Nov; 41(Pt 6):459-63. PubMed ID: 15588434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers.
    Collinson PO; Barnes SC; Gaze DC; Galasko G; Lahiri A; Senior R
    Eur J Heart Fail; 2004 Mar; 6(3):365-8. PubMed ID: 14987590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-center validation of the Response Biomedical Corporation RAMP NT-proBNP assay with comparison to the Roche Diagnostics GmbH Elecsys proBNP assay.
    Lee-Lewandrowski E; Januzzi JL; Green SM; Tannous B; Wu AH; Smith A; Wong A; Murakami MM; Kaczmarek J; Apple FS; Miller WL; Hartman K; Jaffe AS
    Clin Chim Acta; 2007; 386(1-2):20-4. PubMed ID: 17854790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head to head comparison of N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in patients with/without left ventricular systolic dysfunction.
    Vanderheyden M; Bartunek ; Claeys G; Manoharan G; Beckers JF; Ide L
    Clin Biochem; 2006 Jun; 39(6):640-5. PubMed ID: 16516185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal probrain natriuretic peptide as a predictor of short-term outcomes in acute myocardial infarction.
    Puri A; Narain VS; Mehrotra S; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2005; 57(4):304-10. PubMed ID: 16350675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.
    Hess G; Runkel S; Zdunek D; Hitzler WE
    Clin Lab; 2005; 51(3-4):167-72. PubMed ID: 15819172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac troponin T and N-terminal-pro-B type natriuretic peptide reflect myocardial function in preterm infants.
    El-Khuffash A; Davis PG; Walsh K; Molloy EJ
    J Perinatol; 2008 Jul; 28(7):482-6. PubMed ID: 18322550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay.
    Hermsen D; Apple F; Garcia-Beltràn L; Jaffe A; Karon B; Lewandrowski E; Mühlbacher A; Müller R; Ordóñez J; Pagani F; Panteghini M; Plecko T; Jarausch J
    Clin Lab; 2007; 53(1-2):1-9. PubMed ID: 17323819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroendocrine testing in community patients with heart disease: plasma N-terminal proatrial natriuretic peptide predicts morbidity and mortality stronger than catecholamines and heart rate variability.
    Nielsen OW; Rasmussen V; Christensen NJ; Hansen JF
    Scand J Clin Lab Invest; 2004; 64(7):619-28. PubMed ID: 15513318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea.
    Alibay Y; Beauchet A; El Mahmoud R; Schmitt C; Brun-Ney D; Benoit MO; Dubourg O; Boileau C; Jondeau G; Puy H
    Biomed Pharmacother; 2005; 59(1-2):20-4. PubMed ID: 15740931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma N-terminal fragments of natriuretic peptides predict the risk of stroke and atrial fibrillation in men.
    Kurl S; Ala-Kopsala M; Ruskoaho H; Mäkikallio T; Nyyssönen K; Vuolteenaho O; Sivenius J; Salonen JT; Laukkanen JA
    Heart; 2009 Jul; 95(13):1067-71. PubMed ID: 19321489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D
    Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism.
    Kiely DG; Kennedy NS; Pirzada O; Batchelor SA; Struthers AD; Lipworth BJ
    Respir Med; 2005 Oct; 99(10):1286-91. PubMed ID: 16099151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?
    Galasko GI; Lahiri A; Barnes SC; Collinson P; Senior R
    Eur Heart J; 2005 Nov; 26(21):2269-76. PubMed ID: 16040618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study.
    Levy D; Hwang SJ; Kayalar A; Benjamin EJ; Vasan RS; Parise H; Larson MG; Wang TJ; Selhub J; Jacques PF; Vita JA; Keyes MJ; Mitchell GF
    Circulation; 2007 Jun; 115(24):3079-85. PubMed ID: 17533184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study.
    Bionda C; Bergerot C; Ardail D; Rodriguez-Lafrasse C; Rousson R
    Ann Clin Lab Sci; 2006; 36(3):299-306. PubMed ID: 16951271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
    Koch AM; Rauh M; Zink S; Singer H
    Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.